论文部分内容阅读
目的分析黏膜下注射与膀胱灌注吡柔比星对预防膀胱癌复发的疗效。方法将2006年1月到2008年2月间来我院治疗的186例膀胱癌患者随机分为观察组和对照组,每组93例,分别在术中和术后行黏膜下注射和膀胱灌注吡柔比星,对比两组患者的复发率。结果观察组的复发率为7.5%(7/93),对照组的复发率为18.3%(17/93),差异显著。结论黏膜下注射吡柔比星对于预防膀胱癌复发具有显著疗效。
Objective To analyze the effect of submucosal instillation and intravesical instillation of pirarubicin on the prevention of bladder cancer recurrence. Methods A total of 186 patients with bladder cancer who were treated in our hospital from January 2006 to February 2008 were randomly divided into observation group and control group, with 93 cases in each group. Submucosal instillation and intravesical instillation Pirarubicin, compared the recurrence rate of two groups of patients. Results The recurrence rate was 7.5% (7/93) in the observation group and 18.3% (17/93) in the control group, the difference was significant. Conclusion Submucosal injection of pirarubicin has a significant effect on the prevention of bladder cancer recurrence.